Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
United States of America
COVID-19
2022
2021
Americas
Clear all
Type of publications
NITAG documentation
(45)
Systematic reviews (SYSVAC)
(8)
Topics
Available to download in languages
Regions
Americas
(53)
Countries
United States of America
(53)
Argentina
(3)
Bolivia
(2)
Canada
(31)
Chile
(13)
Uruguay
(1)
Diseases
COVID-19
(53)
Cholera
(3)
Ebola
(2)
Hepatitis B
(2)
Herpes zoster
(1)
Human papillomavirus (HPV)
(10)
Influenza
(2)
Measles
(1)
Meningococcal disease
(1)
Mpox // Monkeypox
(1)
Mumps
(1)
Pneumococcal disease
(3)
Rabies
(1)
Rubella
(1)
Vaccine topics
Acceptance
(7)
Coverage
(2)
Efficacy/effectiveness
(2)
Ethical issues
(3)
Safety
(2)
Target population
Adults
(1)
All age groups
(5)
Children
(2)
Healthcare workers
(4)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(4)
Publication date
2022
(17)
2021
(36)
2023
(2)
2020
(49)
53 results found
2022
∙
Dhanani, Lindsay Y. Franz, Berkeley
A Meta-Analysis of COVID-19 Vaccine Attitudes and Demographic Characteristics in the United States
2022
∙
Ripon, R. K. Motahara, U. Alam, A. Ishadi, K. S. Sarker, M. S.
A meta-analysis of COVID-19 vaccines acceptance among Black /African American
2022
∙
Rawal, Smita Tackett, Randall L. Stone, Rebecca H. Young, Henry N.
COVID-19 Vaccination among Pregnant People in the U.S.: A Systematic Review
2022
∙
Rawal, S. Tackett, R. L. Stone, R. H. Young, H. N.
COVID-19 vaccination among pregnant people in the United States: a systematic review
2022
∙
Lieneck, C. Heinemann, K. Patel, J. Huynh, H. Leafblad, A. Moreno, E. Wingfield, C.
Facilitators and Barriers of COVID-19 Vaccine Promotion on Social Media in the United States: A Systematic Review
2022
∙
Wang, Ying Liu, Yu
Multilevel determinants of COVID-19 vaccination hesitancy in the United States: A rapid systematic review
2022
∙
ACIP
ACIP Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines
2022
∙
ACIP
ACIP Update to the Evidence to Recommendations for a Pfizer-BioNTech COVID-19 Booster in Children Ages 5-11 Years
2022
CDC Clinical Considerations for Second COVID-19 Vaccine Booster Dose
2022
∙
Sara Oliver, ACIP
Evidence to recommendation Framework: mRNA COVID-19 vaccine in young children
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register